Statements (32)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:veterinary_medicine
|
gptkbp:activeIngredient |
sarolaner
|
gptkbp:administeredBy |
gptkb:dog
|
gptkbp:approvalYear |
2016
|
gptkbp:approvedBy |
gptkb:FDA
|
gptkbp:contraindication |
use in cats
use in puppies under 6 months |
gptkbp:countryOfOperation |
gptkb:Australia
gptkb:Canada gptkb:United_Kingdom gptkb:United_States |
gptkbp:effect |
1 month
|
gptkbp:form |
chewable tablet
|
https://www.w3.org/2000/01/rdf-schema#label |
Simparica
|
gptkbp:manufacturer |
gptkb:Zoetis
|
gptkbp:mechanismOfAction |
isoxazoline class inhibitor
|
gptkbp:prescriptionStatus |
prescription only
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
vomiting
diarrhea anorexia lethargy |
gptkbp:treatment |
gptkb:Amblyomma_americanum
gptkb:Dermacentor_variabilis gptkb:Ixodes_scapularis gptkb:Rhipicephalus_sanguineus gptkb:Sarcoptes_scabiei Demodex canis |
gptkbp:usedFor |
flea control
tick control |
gptkbp:bfsParent |
gptkb:Zoetis_Inc.
|
gptkbp:bfsLayer |
7
|